225 related articles for article (PubMed ID: 16785693)
1. Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
Cheng KC; Chuang YC; Wu LT; Huang GC; Yu WL
Jpn J Infect Dis; 2006 Jun; 59(3):147-52. PubMed ID: 16785693
[TBL] [Abstract][Full Text] [Related]
2. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
[TBL] [Abstract][Full Text] [Related]
3. Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in Taiwan.
Yu WL; Ko WC; Cheng KC; Chen HE; Lee CC; Chuang YC
Diagn Microbiol Infect Dis; 2008 Aug; 61(4):460-7. PubMed ID: 18455901
[TBL] [Abstract][Full Text] [Related]
4. Survey of CTX-M-3 extended-spectrum beta-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan.
Wu LT; Tsou MF; Wu HJ; Chen HE; Chuang YC; Yu WL
Diagn Microbiol Infect Dis; 2004 Jun; 49(2):125-9. PubMed ID: 15183862
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
Crivaro V; Bagattini M; Salza MF; Raimondi F; Rossano F; Triassi M; Zarrilli R
J Hosp Infect; 2007 Oct; 67(2):135-41. PubMed ID: 17884248
[TBL] [Abstract][Full Text] [Related]
6. CTX-M and TEM as predominant types of extended spectrum beta-lactamases among Serratia marcescens isolated from solid organ recipients.
Mlynarczyk A; Szymanek K; Sawicka-Grzelak A; Pazik J; Buczkowska T; Durlik M; Lagiewska B; Pacholczyk M; Chmura A; Paczek L; Mlynarczyk G
Transplant Proc; 2009 Oct; 41(8):3253-5. PubMed ID: 19857723
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period.
Naumiuk L; Baraniak A; Gniadkowski M; Krawczyk B; Rybak B; Sadowy E; Samet A; Kur J
J Clin Microbiol; 2004 Jul; 42(7):3108-16. PubMed ID: 15243068
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
Park YJ; Park SY; Oh EJ; Park JJ; Lee KY; Woo GJ; Lee K
Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318
[TBL] [Abstract][Full Text] [Related]
9. Extended-spectrum beta-lactamase-producing Serratia marcescens outbreak in a Bulgarian hospital.
Ivanova D; Markovska R; Hadjieva N; Schneider I; Mitov I; Bauernfeind A
J Hosp Infect; 2008 Sep; 70(1):60-5. PubMed ID: 18602186
[TBL] [Abstract][Full Text] [Related]
10. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.
Yu WL; Chuang YC; Walther-Rasmussen J
J Microbiol Immunol Infect; 2006 Aug; 39(4):264-77. PubMed ID: 16926972
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Phoenix Automated Microbiology System for detecting extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens.
Park YJ; Yu JK; Lee S; Park JJ; Oh EJ
Ann Clin Lab Sci; 2007; 37(1):75-8. PubMed ID: 17311873
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
Ku YH; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial outbreak of ceftazidime-resistant Serratia marcescens strains that produce a chromosomal AmpC variant with N235K substitution.
Yatsuyanagi J; Saito S; Konno T; Harata S; Suzuki N; Kato J; Amano K
Jpn J Infect Dis; 2006 Jun; 59(3):153-9. PubMed ID: 16785694
[TBL] [Abstract][Full Text] [Related]
14. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
[TBL] [Abstract][Full Text] [Related]
15. Characterization of class 1 integrons and antimicrobial resistance in CTX-M-3-producing Serratia marcescens isolates from southern Taiwan.
Peng CF; Lee MF; Fu HT; Chen YJ; Hsu HJ
Jpn J Infect Dis; 2007 Sep; 60(5):250-6. PubMed ID: 17881862
[TBL] [Abstract][Full Text] [Related]
16. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
Bin C; Hui W; Renyuan Z; Yongzhong N; Xiuli X; Yingchun X; Yuanjue Z; Minjun C
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):351-7. PubMed ID: 16934430
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan.
Yu WL; Wu LT; Pfaller MA; Winokur PL; Jones RN
Diagn Microbiol Infect Dis; 2003 Apr; 45(4):221-4. PubMed ID: 12729989
[TBL] [Abstract][Full Text] [Related]
20. SME-2-producing Serratia marcescens isolate from Switzerland.
Poirel L; Wenger A; Bille J; Bernabeu S; Naas T; Nordmann P
Antimicrob Agents Chemother; 2007 Jun; 51(6):2282-3. PubMed ID: 17420208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
